Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Matrix Metalloproteinase (MMP) -1, -2, -3 and -9 Promoter Polymorphisms in Colorectal Cancer

NILS ELANDER, PETER SÖDERKVIST and KARIN FRANSÉN
Anticancer Research January 2006, 26 (1B) 791-795;
NILS ELANDER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: nilel463{at}student.liu.se
PETER SÖDERKVIST
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KARIN FRANSÉN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Background: Matrix metalloproteinases (MMPs) are a group of matrix-degrading proteins implicated in several pathological processes, e.g., invasion and metastasis in malignant diseases such as colorectal cancer (CRC). Materials and Methods: One hundred and twenty-seven CRC patients and 208 controls were genotyped for MMP-1, -2, -3 and -9 promoter polymorphisms. The genotyping was performed with PCR/primer-extension/DHPLC or PCR/RFLP. Results: The MMP-1 2G allele was significantly associated with CRC (p=0.037). No significant association between CRC and MMP-2, -3 or -9 polymorphisms was evident. The analysis of polymorphisms in the clinicopathological subgroups displayed no significant associations. Conclusion: The MMP-1 promoter polymorphism seems to affect the susceptibility to CRC, while MMP-2, -3 and -9 polymorphisms appear less likely to have any impact on CRC.

  • MMP-1
  • MMP-2
  • MMP-3
  • MMP-9
  • promoter
  • polymorphism
  • colorectal cancer

Footnotes

  • Received September 28, 2005.
  • Accepted November 30, 2005.
  • Final version accepted December 2, 2005.
  • Copyright© 2006 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 26, Issue 1B
January-February 2006
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Matrix Metalloproteinase (MMP) -1, -2, -3 and -9 Promoter Polymorphisms in Colorectal Cancer
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
4 + 12 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Matrix Metalloproteinase (MMP) -1, -2, -3 and -9 Promoter Polymorphisms in Colorectal Cancer
NILS ELANDER, PETER SÖDERKVIST, KARIN FRANSÉN
Anticancer Research Jan 2006, 26 (1B) 791-795;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Matrix Metalloproteinase (MMP) -1, -2, -3 and -9 Promoter Polymorphisms in Colorectal Cancer
NILS ELANDER, PETER SÖDERKVIST, KARIN FRANSÉN
Anticancer Research Jan 2006, 26 (1B) 791-795;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Association of Matrix Metalloproteinase-7 Genotypes With Prostate Cancer Risk
  • The Contribution of Matrix Metalloproteinase-7 Promoter Genotypes to Hepatocellular Carcinoma Susceptibility
  • Role of Matrix Metallopeptidase-2 Genotypes in Taiwanese Patients With Colorectal Cancer
  • The Association of MMP-11 Promoter Polymorphisms With Susceptibility to Lung Cancer in Taiwan
  • The Contribution of MMP-7 Promoter Polymorphisms to Taiwan Lung Cancer Susceptibility
  • Association of Matrix Metalloproteinase-7 Genotypes with the Risk of Bladder Cancer
  • Association of Matrix Metalloproteinase-8 Genotypes with the Risk of Bladder Cancer
  • The Association of Matrix Metalloproteinase-1 Promoter Polymorphisms with Prostate Cancer in Taiwanese Patients
  • The Association of Matrix Metalloproteinase-1 Promoter Polymorphisms with Breast Cancer
  • Association of Matrix Metalloproteinase-7 Genotypes to the Risk of Oral Cancer in Taiwan
  • The Contribution of Matrix Metalloproteinase-1 Promoter Genotypes in Taiwan Lung Cancer Risk
  • Contribution of Matrix Metalloproteinase-7 Genotypes to the Risk of Non-solid Tumor, Childhood Leukemia
  • The Contribution of Matrix Metalloproteinase-7 Promoter Genotypes in Breast Cancer in Taiwan
  • The Contribution of Matrix Metalloproteinase-8 Promoter Polymorphism to Oral Cancer Susceptibility
  • The Contribution of MMP-8 Promoter Polymorphisms in Lung Cancer
  • The Contribution of MMP-7 Promoter Polymorphisms in Renal Cell Carcinoma
  • Associations between Single Nucleotide Polymorphisms of MMP2, VEGF, and HIF1A Genes and the Risk of Developing Colorectal Cancer
  • Missense Polymorphisms in Matrix Metalloproteinase Genes and Skin Cancer Risk
  • No Association of MMP-7, MMP-8, and MMP-21 Polymorphisms with the Risk of Hepatocellular Carcinoma in a Chinese Population
  • Functional polymorphisms in the promoters of MMP-1, MMP-2, MMP-3, MMP-9, MMP-12 and MMP-13 are not associated with hepatocellular carcinoma risk
  • Google Scholar

More in this TOC Section

  • Neoadjuvant Radiochemotherapy for Locally Advanced Rectal Cancer: A Single-institutional Real-world Study
  • Cytoreductive Surgery With or Without Intraperitoneal Chemotherapy for Peritoneal Spread from Appendiceal Neoplasms and Cancers
  • Feasibility of Minimally Invasive Surgery for Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy: A Four-arm Comparative Study
Show more Clinical Studies
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire